| William Francis Gabrielli Jr, MD, PHD | |
|
3901 Rainbow Blvd, Dept. Of Psychiatry Mail Stop 4015, Kansas City, KS 66160-0001 | |
| (913) 588-6401 | |
| (913) 588-8811 |
| Full Name | William Francis Gabrielli Jr |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 37 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790894681 | NPI | - | NPPES |
| 100145880B | Other | KS | KANSAS MEDICAID |
| 203750104 | Medicaid | MO | |
| 260027872 | Other | RAILROAD MEDICARE | |
| 19747045 | Other | MO | BCBS KANSAS CITY |
| 100145880A | Medicaid | KS | |
| 19747035 | Other | MO | BCBS KANSAS CITY |
| 625791 | Other | KS | FIRSTGUARD |
| 625790 | Other | KS | FIRSTGUARD |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
The American Heart Association and the American College of Cardiology are calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth.
OptumHealth today announced that it will offer an unlimited lifetime benefit for specific coverage as a standard provision of its excess loss insurance policy.
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Although several types of pain assessment tools are available to help clinicians evaluate pain in older people, too often the sole initial emphasis is to gauge pain intensity instead of determining how the pain affects function and the need for treatment, according to research presented at the American Pain Society Annual Scientific Meeting.
› Verified 9 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
The American Heart Association and the American College of Cardiology are calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth.
OptumHealth today announced that it will offer an unlimited lifetime benefit for specific coverage as a standard provision of its excess loss insurance policy.
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Although several types of pain assessment tools are available to help clinicians evaluate pain in older people, too often the sole initial emphasis is to gauge pain intensity instead of determining how the pain affects function and the need for treatment, according to research presented at the American Pain Society Annual Scientific Meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Francis Gabrielli Jr, MD, PHD 3901 Rainbow Blvd, Mail Stop 4015, Kansas City, KS 66160 Ph: (913) 588-6401 | William Francis Gabrielli Jr, MD, PHD 3901 Rainbow Blvd, Dept. Of Psychiatry Mail Stop 4015, Kansas City, KS 66160-0001 Ph: (913) 588-6401 |
News Archive
The American Heart Association and the American College of Cardiology are calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth.
OptumHealth today announced that it will offer an unlimited lifetime benefit for specific coverage as a standard provision of its excess loss insurance policy.
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Although several types of pain assessment tools are available to help clinicians evaluate pain in older people, too often the sole initial emphasis is to gauge pain intensity instead of determining how the pain affects function and the need for treatment, according to research presented at the American Pain Society Annual Scientific Meeting.
› Verified 9 days ago
Joan M. T. Collison, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 4015, Kansas City, KS 66160 Phone: 913-588-1300 Fax: 913-588-1310 | |
Dr. Andrea Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3599 Rainbow Blvd, Kansas City, KS 66103 Phone: 913-588-6970 | |
James S Appelbaum, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 440, Kansas City, KS 66112 Phone: 913-596-7286 Fax: 913-596-7248 | |
Dr. Robert T. Reynders, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160 Phone: 913-588-3807 | |
Ahmad Abuzinadah, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Ms 2012, Kansas City, KS 66160 Phone: 913-588-6970 Fax: 913-588-6965 | |
Dr. Thomas Bryan Hall, Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Department Of Psychiatry, Kansas City, KS 66160 Phone: 913-588-6400 | |
Debra Jean Kelsh, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-1304 Fax: 913-588-1310 |